Market Commentary     28-Feb-25
Mid-Session
Market under pressure; IT shares plunge amid global cues
The key equity benchmarks traded with substantial losses in morning trade due to ongoing FII selling and concerns over the tariffs situation. The Nifty dropped below 22,300 level. IT shares declined for the seventh consecutive trading session.

At 10:25 IST, the barometer index, the S&P BSE Sensex, declined 829.69 points or 1.11% to 73,777. The Nifty 50 index dropped 260.65 points or 1.16% to 22,284.40.

The broader market underperformed frontline indices. The S&P BSE Mid-Cap index declined 1.86% and the S&P BSE Small-Cap index fell 1.96%.

The market breadth was weak. On the BSE, 617 shares rose and 2,947 shares fell. A total of 137 shares were unchanged.

SEBI Leadership Change:

Tuhin Kanta Pandey has been appointed as the 11th chairperson of the Securities and Exchange Board of India (SEBI) for a three-year term. The current Finance Secretary will replace Madhabi Puri Buch, who will complete her tenure as SEBI's first woman chairperson on Friday, February 28, 2025.

Buzzing Index:

The Nifty IT declined 3.66% to 37,521. The index dropped 9.51% in seven consecutive trading session.

Persistent Systems (down 5.08%), Tech Mahindra (down 4.65%), Coforge (down 4.25%), Mphasis (down 4.12%) and Wipro (down 3.99%) were the top losers. Among the other losers were HCL Technologies (down 3.57%), Infosys (down 3.26%), LTIMindtree (down 2.97%), Tata Consultancy Services (down 2.78%) and L&T Technology Services (down 2.27%) declined.

Stocks in Spotlight:

Tata Power Company shed 0.73%. The company announced that its a wholly owned subsidiary, TP Solar, has secured a contract worth Rs 632 crore from the Solar Energy Corporation of India (SECI) for the supply of 292.5 MWp domestic content requirement (DCR) solar modules.

Rail Vikas Nigam (RVNL) declined 2.25%. The company has received a Letter of Acceptance (LoA) from Central Railway for a project valued at Rs 135.66 crore.

Biocon fell 2%. The company has announced the launch of its GLP-1 peptide Liraglutide for diabetes and obesity in the United Kingdom (U.K.).

Previous News
  Biocon’s board OKs to raise Rs 4,500-cr
 ( Hot Pursuit - 24-Apr-25   08:11 )
  Board of Biocon approves fund raising up to Rs 4,500 cr
 ( Corporate News - 23-Apr-25   20:05 )
  Tata Power arm signs landmark PPA with Tata Motors for 131 MW hybrid project
 ( Hot Pursuit - 22-Apr-25   12:29 )
  Tata Power Company to announce Quarterly Result
 ( Corporate News - 22-Apr-25   10:08 )
  Tata Power Renewable Energy signs PPA with Tata Motors
 ( Corporate News - 21-Apr-25   19:40 )
  Biocon to consider fund Raising
 ( Corporate News - 21-Apr-25   09:37 )
  Biocon surges on U.S. deal for Eylea copycat drug
 ( Hot Pursuit - 15-Apr-25   09:58 )
  Tata Power gains as arm inks pact with NTPC for 200 MW FDRE project
 ( Hot Pursuit - 15-Apr-25   09:44 )
  Biocon Biologics inks a settlement and license agreement with Regeneron
 ( Corporate News - 15-Apr-25   09:29 )
  Tata Power’s arm inks pact with NTPC for 200 MW FDRE project
 ( Hot Pursuit - 14-Apr-25   14:40 )
  Rail Vikas Nigam successfully bids for Rs 143 cr project of Southern Railway
 ( Corporate News - 11-Apr-25   14:40 )
Other Stories
  Benchmarks trade with moderate losses; pharma shares decline
  25-Apr-25   14:34
  Nifty trades below 24,050; European mrkt opens higher
  25-Apr-25   13:34
  Sensex slumps 946 pts; Nifty below 23,950; VIX soars 5%
  25-Apr-25   12:35
  Market under pressure; PSU Bank shares drop for 3rd day
  25-Apr-25   11:32
  Market trade lower; media shares decline
  25-Apr-25   10:36
  Indices edge lower; breadth strong
  25-Apr-25   09:39
  Indices extend losses; Nifty slips below 24,250 mark
  24-Apr-25   14:33
  Nifty trades below 24,300; European mrkt opens lower
  24-Apr-25   13:36
  Sensex tumbles 301 pts; FMCG shares slides; VIX jumps 2.74%
  24-Apr-25   12:33
  Indices trade lower; pharma shares rally for 5th day
  24-Apr-25   11:32
Back Top